autologous bone graft
Cell therapyexperimental
Clinical trial activity
6 trials · 11 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2004 (NCT01690260)
Timeline
Indications
Mechanism of action
- Unspecified targetTissue restoration
tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- autologous bone graft
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04533880 | N/A | Aug 31, 2020 | New York University |
| NCT04294004 | Phase 2 | Mar 6, 2020 | Factory CRO, Harvard University, Kuros Biosurgery AG |
| NCT03046173 | N/A | May 31, 2014 | Deyang Stomatological Hospital |
| NCT01982045 | N/A | Oct 31, 2013 | NuVasive, Utrecht University |
| NCT00310440 | N/A | Jan 31, 2006 | CeraPedics, Inc |
| NCT01690260 | Phase 1 | Sep 1, 2004 | Aalborg University, Government of Denmark, Medtronic |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (11)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Aalborg University | Academic/Hospital | 1 | 0 | 1 | 2004 |
| CeraPedics, Inc | For profit | 1 | 1 | 1 | 2006 |
| Deyang Stomatological Hospital | Academic/Hospital | 1 | 1 | 1 | 2014 |
| Factory CRO | For profit | 1 | 0 | 1 | 2020 |
| Government of Denmark | Government | 1 | 1 | 1 | 2004 |
| Harvard University | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Kuros Biosurgery AG | For profit | 1 | 1 | 1 | 2020 |
| Medtronic | For profit | 1 | 0 | 1 | 2004 |
| New York University | Academic/Hospital | 1 | 1 | 1 | 2020 |
| NuVasive | For profit | 1 | 0 | 1 | 2013 |
| Utrecht University | Academic/Hospital | 1 | 1 | 1 | 2013 |
11 organizations
Page 1 / 1